help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2009-0458
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Murray, E. K.
Right arrow Articles by Forger, N. G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murray, E. K.
Right arrow Articles by Forger, N. G.
Endocrinology Vol. 150, No. 9 4241-4247
Copyright © 2009 by The Endocrine Society

Epigenetic Control of Sexual Differentiation of the Bed Nucleus of the Stria Terminalis

Elaine K. Murray, Annie Hien, Geert J. de Vries and Nancy G. Forger

Neuroscience and Behavior Program, Department of Psychology and Center for Neuroendocrine Studies, University of Massachusetts, Amherst, Massachusetts 01003

Address all correspondence and requests for reprints to: Elaine K. Murray, Department of Psychology, 529 Tobin Hall, University of Massachusetts, Amherst, Massachusetts 01003. E-mail: ekmurray{at}nsm.umass.edu.

The principal nucleus of the bed nucleus of the stria terminalis (BNSTp) is larger in volume and contains more cells in male than female mice. These sex differences depend on testosterone and arise from a higher rate of cell death during early postnatal life in females. There is a delay of several days between the testosterone surge at birth and sexually dimorphic cell death in the BNSTp, suggesting that epigenetic mechanisms may be involved. We tested the hypothesis that chromatin remodeling plays a role in sexual differentiation of the BNSTp by manipulating the balance between histone acetylation and deacetylation using a histone deacetylase inhibitor. In the first experiment, a single injection of valproic acid (VPA) on the day of birth increased acetylation of histone H3 in the brain 24 h later. Next, males, females, and females treated neonatally with testosterone were administered VPA or saline on postnatal d 1 and 2 and killed at 21 d of age. VPA treatment did not influence volume or cell number of the BNSTp in control females but significantly reduced both parameters in males and testosterone-treated females. As a result, the sex differences were eliminated. VPA did not affect volume or cell number in the suprachiasmatic nucleus or the anterodorsal nucleus of the thalamus, which also did not differ between males and females. These findings suggest that a disruption in histone deacetylation may lead to long-term alterations in gene expression that block the masculinizing actions of testosterone in the BNSTp.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
M. M. McCarthy, A. P. Auger, T. L. Bale, G. J. De Vries, G. A. Dunn, N. G. Forger, E. K. Murray, B. M. Nugent, J. M. Schwarz, and M. E. Wilson
The Epigenetics of Sex Differences in the Brain
J. Neurosci., October 14, 2009; 29(41): 12815 - 12823.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. J. Baum
New Evidence that an Epigenetic Mechanism Mediates Testosterone-Dependent Brain Masculinization
Endocrinology, September 1, 2009; 150(9): 3980 - 3982.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society